HMS (HMSY) Downgraded to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of HMS (NASDAQ:HMSY) from a hold rating to a sell rating in a report released on Wednesday.
According to Zacks, “HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. “
A number of other equities analysts also recently commented on the company. BidaskClub upgraded HMS from a sell rating to a hold rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a hold rating and issued a $16.00 target price on shares of HMS in a research report on Sunday, November 19th. Canaccord Genuity reduced their target price on HMS from $22.00 to $17.00 and set a buy rating on the stock in a research report on Monday, November 6th. Robert W. Baird restated a buy rating and issued a $17.00 target price on shares of HMS in a research report on Friday, November 10th. Finally, Jefferies Group restated a neutral rating on shares of HMS in a research report on Sunday, November 5th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company. The company currently has an average rating of Hold and a consensus price target of $20.50.
HMS (NASDAQ:HMSY) last announced its quarterly earnings data on Friday, February 23rd. The business services provider reported $0.15 EPS for the quarter, missing the Zacks’ consensus estimate of $0.22 by ($0.07). HMS had a return on equity of 7.33% and a net margin of 7.56%. The company had revenue of $148.49 million for the quarter, compared to analysts’ expectations of $136.77 million. During the same quarter in the previous year, the business posted $0.20 EPS. The business’s quarterly revenue was up 18.2% compared to the same quarter last year. equities analysts predict that HMS will post 0.65 EPS for the current fiscal year.
HMS announced that its board has approved a share buyback plan on Friday, November 3rd that allows the company to repurchase $50.00 million in outstanding shares. This repurchase authorization allows the business services provider to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.
Large investors have recently bought and sold shares of the business. Penbrook Management LLC purchased a new stake in shares of HMS in the 4th quarter valued at $541,000. Xact Kapitalforvaltning AB purchased a new stake in shares of HMS in the 4th quarter valued at $226,000. Fairpointe Capital LLC raised its holdings in shares of HMS by 3.3% in the 4th quarter. Fairpointe Capital LLC now owns 157,400 shares of the business services provider’s stock valued at $2,668,000 after buying an additional 5,000 shares during the period. Segall Bryant & Hamill LLC raised its holdings in shares of HMS by 71.5% in the 4th quarter. Segall Bryant & Hamill LLC now owns 301,096 shares of the business services provider’s stock valued at $5,104,000 after buying an additional 125,507 shares during the period. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of HMS in the 4th quarter valued at $691,000. Institutional investors own 96.62% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “HMS (HMSY) Downgraded to Sell at Zacks Investment Research” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.dailypolitical.com/2018/03/03/hms-hmsy-downgraded-to-sell-at-zacks-investment-research.html.
HMS Holdings Corp. is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. It provides coordination of benefits services to government, and private healthcare payers and sponsors. Its payment integrity services ensure that healthcare claims billed are accurate and appropriate.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.